Assistant Professor, Medicine, UCSF School of Medicine
Oncology
Dr. Weiyun Z. Ai, MD
|
|
Give Review
Weiyun Z. Ai, MD practices Oncology. She researched medicine at Stanford University School of Medicine. Stanford University School of Medicine is a one of the best medicals schools. Stanford University School of Medicine is ranked 2/25 in Research/PrimaryCare. She received 1 awards: "CMS Meaningful Use Stage 1 Certification". Dr. Weiyun Z. Ai has written publications. She has 24 publications published with PubMed. The lastest publication is: 'Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk Following Autologous Hematopoietic S...' Weiyun accepts Medicare payments and is listed with Medicare.gov.
Publications
- Long-Term Outcomes of Patients with Intermediate-Risk Acute Myeloid Leukemia Treated with Autologous Hematopoietic Cell Transplant in First Complete Remission.
- A Phase I Study of Targeted, Dose-Escalated Intravenous Busulfan in Combination With Etoposide as Myeloablative Therapy for Autologous Stem Cell Transplantation in Acu...
- Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for Acute promyelocytic leukemia: a multi-center analysis.
- Hematopoietic Cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipients.
- Outcomes After Diagnosis of Mycosis Fungoides and Sézary Syndrome Before 30 Years of Age: A Population-Based Study.
- Racial patterns of extranodal natural killer/T-Cell lymphoma, nasal type, in California: a population-based study.
- In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase I/II study.
- Acneiform presentation of primary cutaneous follicle center Lymphoma.
- Hodgkin Lymphoma.
- Prolonged disease-free survival and overall survival with CVP alternating with fludarabine in advanced follicular Lymphoma.
- In situ vaccination with a TLR9 agonist induces Systemic lymphoma regression: a phase I/II study.
- C-C chemokine receptor 1 expression in human hematolymphoid neoplasia.
- Left ventricular rupture due to HIV-associated T-Cell lymphoma.
- Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular Lymphoma.
- Follicular lymphoma B Cells induce the conversion of conventional CD4+ T Cells to T-regulatory Cells.
- ''Minor'' BCL2 breakpoints in follicular Lymphoma: frequency and correlation with grade and disease presentation in 236 cases.
- Management of advanced stage Hodgkin Lymphoma.
- [Analysis of clinical characteristics and treatment outcome of bilateral and unilateral sudden sensorineural hearing loss].
- Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem Cells and for Cell migration and invasion.
- CCAAT displacement protein binds to and negatively regulates human papillomavirus type 6 E6, E7, and E1 promoters.
- Yin yang 1 negatively regulates the differentiation-specific E1 promoter of human papillomavirus type 6.
- Deficiency of Kruppel-like factor KLF4 in myeloid-derived suppressor Cells inhibits tumor pulmonary metastasis in mice accompanied by decreased fibrocytes.
- Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk Following Autologous Hematopoietic S...
Schools
Stanford University
Stanford University School Med
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Basal Cell Carcinoma
- Bladder Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Stanford University -
UCSF -
Stanford University School of Medicine
Hospital
-
UCSF Medical Center
Drug Facts
| NPI NUMBER | 1649346842 | |
| NPPES Provider LastName | AI | |
| NPPES Provider FirstName | WEIYUN | |
| NPPES Provider ZIPCode | 941432202 | |
| NPPES Provider State | CA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 715.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 18.0 | |
| Percent Opioid Claims | 2.52 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1649346842 |
| Last Name Of The Provider | AI |
| First Name Of The Provider | WEIYUN |
| View All |
Similar Doctors
|
|
Dr. Garrett A. Smith, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Terence W. Friedlander, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew C. Hsieh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard B. Kleckner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence Fong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ann K. Lanzerotti, MD |
|
|
Dr. Stephanie J. Jeske, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. James M. Kahn, DO |
|
|
Dr. Thomas G. Roberts Jr., MD |
|
|
Dr. Daniel W. Sherbenou, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melisa L. Wong, MD
This Doctor is OpenDoctor Recommended.
|